BlackRock Institutional Trust’s AIM ImmunoTech AIM Stock Holding History

BlackRock Institutional Trust’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$331K	Hold	109	–	–	﹤0.01%	3522
2016 Q3	$604K	Hold	109	–	–	﹤0.01%	3442
2016 Q2	$663K	Hold	109	–	–	﹤0.01%	3436
2016 Q1	$766K	Hold	109	–	–	﹤0.01%	3356
2015 Q4	$463K	Hold	109	–	–	﹤0.01%	3523
2015 Q3	$981K	Hold	109	–	–	﹤0.01%	3342
2015 Q2	$1.18M	Buy	109 +2	+2%	+$24.8K	﹤0.01%	3312
2015 Q1	$1.28M	Buy	107 +10	+10%	+$125K	﹤0.01%	3272
2014 Q4	$1.27M	Buy	97 +3	+3%	+$44.8K	﹤0.01%	3280
2014 Q3	$1.59M	Buy	94 +8	+9%	+$123K	﹤0.01%	3177
2014 Q2	$1.4M	Buy	86 +10	+13%	+$179K	﹤0.01%	3330
2014 Q1	$1.59M	Buy	76 +31	+69%	+$656K	﹤0.01%	3262
2013 Q4	$631K	Buy	45 +3	+7%	+$36.2K	﹤0.01%	3524
2013 Q3	$522K	Hold	42	–	–	﹤0.01%	3523
2013 Q2	$496K	Buy	+42	New	+$501K	﹤0.01%	3486

Other funds holding AIM

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OAM

Occidental Asset Management Burlingame, California $844M AUM 20.95% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Institutional Trust's AIM Position: Q4 2016 in Review

BlackRock Institutional Trust held its AIM ImmunoTech (AIM) position steady in Q4 2016 at 109 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #3522.

BlackRock Institutional Trust first reported a position in AIM in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.59M in Q1 2014. 14 funds tracked by Wall St. Rank hold AIM as of Q4 2016.

BlackRock Institutional Trust held 109 shares of AIM ImmunoTech worth $331K as of Q4 2016.
BlackRock Institutional Trust left its AIM ImmunoTech share count unchanged in Q4 2016.
AIM ImmunoTech made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3522 holding.
BlackRock Institutional Trust first reported a position in AIM ImmunoTech in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's AIM ImmunoTech position peaked at $1.59M in Q1 2014.
14 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.